This is a summary of the European public assessment report (EPAR) for Somac Control. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Somac Control.
Therapeutic Indication
### Therapeutic indication Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
Therapeutic Area (MeSH)
N/AATC Code
A02BC02
ATC Item
pantoprazole
Pharmacotherapeutic Group
Proton pump inhibitors
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| pantoprazole | N/A | 泮托拉唑 |
EMA Name
Somac Control
Medicine Name
Somac Control
Aliases
N/ANo risk management plan link.
